FundPlus
Investor profile
Venture capital
FundPlus has backed 9 European tech companies across 12 funding rounds between 2021 and 2025, joining rounds totalling €742M. Most active in Healthtech. Data as of Nov 2026.
Also recorded as: Fund plus
Deals
12
distinct rounds
Companies
9
backed
Active span
2021–2025
5 yrs
Total round €
€742M
sum of rounds joined
Deals by year
distinct rounds / yearFundPlus — deals by year — interactive chart.
Data table
| FundPlus — deals by year | |
|---|---|
| 2021 | 3 |
| 2022 | 7 |
| 2025 | 2 |
Top sectors
by dealsFundPlus — top sectors — interactive chart.
Data table
| FundPlus — top sectors | |
|---|---|
| Healthtech | 12 |
Stages
by dealsFundPlus — stages — interactive chart.
Data table
| FundPlus — stages | |
|---|---|
| Series B | 6 |
| Series A | 3 |
| Series C | 2 |
| Seed | 1 |
Countries
by dealsFundPlus — countries — interactive chart.
Data table
| FundPlus — countries | |
|---|---|
| Belgium | 4 |
| Germany | 3 |
| France | 2 |
| Netherlands | 2 |
| Spain | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Andera Partners4
- Hadean Ventures3
- High-Tech Gründerfonds (HTGF)3
- INKEF Capital3
- Bayern Kapital2
- BioMedPartners2
- Coparion2
- CR-CP Life Science Fund2
- Curie Capital2
- FIRST Fund2
- InvestSud2
- Kurma Partners2
- LSP2
- New Science Ventures2
- OCCIDENT2
- Omnes Capital2
- Seroba Life Sciences2
- Seventure Partners2
- SRIW Life Sciences2
- Sunstone Life Science Ventures2
- Utrecht Health Seed Fund2
- V-Bio Ventures2
- VIVES Louvain Technology Fund2
- Ackermans & van Haaren1
- Ascenta Capital1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Tubulis Technologies | Germany | 2 | €368M |
| Cardior Pharmaceuticals | Germany | 1 | €64M |
| Novadip Biosciences | Belgium | 2 | €59M |
| Coave Therapeutics | France | 2 | €53M |
| Minoryx Therapeutics | Spain | 1 | €51M |
| TargED Biopharmaceutical | Netherlands | 1 | €39M |
| TargED Biopharmaceuticals | Netherlands | 1 | €39M |
| eTheRNA | Belgium | 1 | €39M |
| AstriVax | Belgium | 1 | €30M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Tubulis Technologies | Series C | €308M | 2025-10 |
| Cardior Pharmaceuticals | Series B | €64M | 2021-08 |
| Tubulis Technologies | Series B | €60M | 2022-05 |
| Minoryx Therapeutics | Series C | €51M | 2022-05 |
| Novadip Biosciences | Series B | €40M | 2022-11 |
| eTheRNA | Series B | €39M | 2022-08 |
| TargED Biopharmaceuticals | Series A | €39M | 2022-02 |
| TargED Biopharmaceutical | Series A | €39M | 2022-02 |
| Coave Therapeutics | Series A | €32M | 2025-01 |
| AstriVax | Seed | €30M | 2022-08 |